Nkx-2.5 Activators
The chemical class of Nkx-2.5 activators encompasses a spectrum of compounds with the capacity to modulate the activity of Nkx-2.5, a crucial transcription factor involved in cardiac development and gene expression. These activators, whether direct or indirect, shed light on the intricate regulatory network governing Nkx-2.5, providing insights into avenues for manipulating cardiac gene expression. Among the identified activators is BDMC (12-O-tetradecanoylphorbol-13-acetate), a phorbol ester that indirectly activates Nkx-2.5 by modulating the PKC signaling pathway. BDMC, designed as a PKC activator, demonstrates a unique dual role by influencing Nkx-2.5, underscoring the complexity of kinase signaling in cardiac development. Similarly, A769662, an AMP-activated protein kinase (AMPK) activator, indirectly impacts Nkx-2.5 by modulating cellular energy status. This highlights the intriguing connection between cellular energy metabolism and Nkx-2.5 activity, providing an avenue for manipulating cardiac gene expression through metabolic pathways.
Isoproterenol, a β-adrenergic receptor agonist, indirectly activates Nkx-2.5 by stimulating the cAMP-PKA signaling pathway. This emphasizes the role of sympathetic signaling in influencing Nkx-2.5, linking adrenergic receptor activation to cardiac gene expression. Additionally, SB431542, a selective inhibitor of the TGF-β type I receptor, ALK5, indirectly activates Nkx-2.5 by disrupting the inhibitory influence of TGF-β.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(E,E)-Bisdemethoxycurcumin | 33171-05-0 | sc-503808 | 25 mg | $380.00 | ||
BDMC (12-O-tetradecanoylphorbol-13-acetate) indirectly activates Nkx-2.5 by modulating the PKC signaling pathway. As a phorbol ester, BDMC acts as a potent activator of PKC, and the subsequent downstream effects influence Nkx-2.5 activation, suggesting a role in the regulation of cardiac gene expression and development. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A769662 is an AMP-activated protein kinase (AMPK) activator that indirectly influences Nkx-2.5 activation through the AMPK signaling pathway. By activating AMPK, A769662 modulates cellular energy status, leading to downstream effects that impact Nkx-2.5, providing insights into the link between cellular energy metabolism and cardiac development. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a β-adrenergic receptor agonist, indirectly activates Nkx-2.5 by stimulating the cAMP-PKA signaling pathway. Through activation of β-adrenergic receptors, Isoproterenol elevates intracellular cAMP levels, leading to PKA activation and subsequent modulation of Nkx-2.5 activity, highlighting the role of sympathetic signaling in cardiac gene expression. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Rosiglitazone, a PPAR-γ agonist, indirectly activates Nkx-2.5 through the PPAR-γ signaling pathway. By activating PPAR-γ, Rosiglitazone influences downstream events that impact Nkx-2.5, providing a connection between PPAR-γ-mediated pathways and cardiac gene expression, suggesting a potential avenue for modulating Nkx-2.5 activity. | ||||||
GW501516 | 317318-70-0 | sc-202642 sc-202642A | 1 mg 5 mg | $82.00 $179.00 | 28 | |
GW501516 is a selective PPAR-δ agonist that indirectly influences Nkx-2.5 activation through cross-talk between PPAR-δ and Nkx-2.5-regulated pathways. By activating PPAR-δ, GW501516 modulates downstream events that impact Nkx-2.5, suggesting a potential role in the intricate network of signaling events governing cardiac gene expression and development. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Propranolol, a non-selective β-adrenergic receptor antagonist, indirectly activates Nkx-2.5 by inhibiting the β-adrenergic signaling pathway. By blocking β-adrenergic receptors, Propranolol disrupts the negative regulatory influence on Nkx-2.5, providing a pharmacological means to influence cardiac gene expression and development. | ||||||
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $43.00 $63.00 $156.00 $260.00 $510.00 $31.00 | 37 | |
Metformin, an AMP-activated protein kinase (AMPK) activator, indirectly influences Nkx-2.5 activation through the AMPK signaling pathway. By activating AMPK, Metformin modulates cellular energy status, leading to downstream effects that impact Nkx-2.5, highlighting the link between cellular energy metabolism and cardiac development. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, an adenylyl cyclase activator, indirectly activates Nkx-2.5 by stimulating the cAMP-PKA signaling pathway. Through activation of adenylyl cyclase, Forskolin elevates intracellular cAMP levels, leading to PKA activation and subsequent modulation of Nkx-2.5 activity, highlighting the connection between cAMP signaling and cardiac gene expression. | ||||||